These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 27415469)

  • 1. Bioengineered non-coding RNA agent (BERA) in action.
    Duan Z; Yu AM
    Bioengineered; 2016 Nov; 7(6):411-417. PubMed ID: 27415469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineering of noncoding RNAs for research agents and therapeutics.
    Ho PY; Yu AM
    Wiley Interdiscip Rev RNA; 2016; 7(2):186-97. PubMed ID: 26763749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs.
    Petrek H; Batra N; Ho PY; Tu MJ; Yu AM
    Appl Microbiol Biotechnol; 2019 Aug; 103(15):6107-6117. PubMed ID: 31187211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth.
    Petrek H; Yan Ho P; Batra N; Tu MJ; Zhang Q; Qiu JX; Yu AM
    Biochem Pharmacol; 2021 Jul; 189():114392. PubMed ID: 33359565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches for efficient  in vivo fermentation production of noncoding RNAs.
    Yu AM; Batra N; Tu MJ; Sweeney C
    Appl Microbiol Biotechnol; 2020 Mar; 104(5):1927-1937. PubMed ID: 31953559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and Purification of tRNA/ pre-miRNA-Based Recombinant Noncoding RNAs.
    Tu MJ; Wright HK; Batra N; Yu AM
    Methods Mol Biol; 2021; 2323():249-265. PubMed ID: 34086286
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Li PC; Tu MJ; Ho PY; Batra N; Tran MML; Qiu JX; Wun T; Lara PN; Hu X; Yu AX; Yu AM
    Theranostics; 2021; 11(10):4858-4871. PubMed ID: 33754032
    [No Abstract]   [Full Text] [Related]  

  • 8. Promoter-based identification of novel non-coding RNAs reveals the presence of dicistronic snoRNA-miRNA genes in Arabidopsis thaliana.
    Qu G; Kruszka K; Plewka P; Yang SY; Chiou TJ; Jarmolowski A; Szweykowska-Kulinska Z; Echeverria M; Karlowski WM
    BMC Genomics; 2015 Nov; 16():1009. PubMed ID: 26607788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioengineered RNA Therapy in Patient-Derived Organoids and Xenograft Mouse Models.
    Tu MJ; Yi CM; Traber GM; Yu AM
    Methods Mol Biol; 2022; 2521():191-206. PubMed ID: 35732999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNAs and potential therapeutic targeting in cancer.
    Toden S; Zumwalt TJ; Goel A
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188491. PubMed ID: 33316377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular RNA interference therapy: the broadening tool and target spectrum.
    Poller W; Tank J; Skurk C; Gast M
    Circ Res; 2013 Aug; 113(5):588-602. PubMed ID: 23948584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer.
    Grillone K; Caridà G; Luciano F; Cordua A; Di Martino MT; Tagliaferri P; Tassone P
    J Transl Med; 2024 Aug; 22(1):731. PubMed ID: 39103911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.
    Traber GM; Yu AM
    J Pharmacol Exp Ther; 2023 Jan; 384(1):133-154. PubMed ID: 35680378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Representation of non-coding RNA-mediated regulation of gene expression using the Gene Ontology.
    Antonazzo G; Gaudet P; Lovering RC; Attrill H
    RNA Biol; 2024 Jan; 21(1):36-48. PubMed ID: 39374113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNAs in endometriosis: a narrative review.
    Panir K; Schjenken JE; Robertson SA; Hull ML
    Hum Reprod Update; 2018 Jul; 24(4):497-515. PubMed ID: 29697794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics.
    Cuciniello R; Filosa S; Crispi S
    J Exp Clin Cancer Res; 2021 Dec; 40(1):383. PubMed ID: 34863235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy.
    Ho PY; Duan Z; Batra N; Jilek JL; Tu MJ; Qiu JX; Hu Z; Wun T; Lara PN; DeVere White RW; Chen HW; Yu AM
    J Pharmacol Exp Ther; 2018 Jun; 365(3):494-506. PubMed ID: 29602831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNAs and their bioengineering applications for neurological diseases.
    Das T; Das TK; Khodarkovskaya A; Dash S
    Bioengineered; 2021 Dec; 12(2):11675-11698. PubMed ID: 34756133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA (Epi)genetics in cardiovascular diseases.
    Elia L; Condorelli G
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):11-6. PubMed ID: 26205296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.